CNM Publications 2009 to Present

Found 95 results
Author Title [ Type(Desc)] Year
Journal Article
Seo JWoong, Baek H, Mahakian LM, Kusunose J, Hamzah J, Ruoslahti E, Ferrara KW.  2014.  (64)Cu-labeled LyP-1-dendrimer for PET-CT imaging of atherosclerotic plaque.. Bioconjug Chem. 25(2):231-9.
Kitazume S, Imamaki R, Ogawa K, Komi Y, Futakawa S, Kojima S, Hashimoto Y, Marth JD, Paulson JC, Taniguchi N.  2010.  Alpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling.. J Biol Chem. 285(9):6515-21.
Haspel N, Zanuy D, Nussinov R, Teesalu T, Ruoslahti E, Alemán C.  2011.  Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach.. Biochemistry. 50(10):1755-62.
Park J-H, Gu L, von Maltzahn G, Ruoslahti E, Bhatia SN, Sailor MJ.  2009.  Biodegradable luminescent porous silicon nanoparticles for in vivo applications.. Nat Mater. 8(4):331-6.
Sturgill ER, Aoki K, Lopez PHH, Colacurcio D, Vajn K, Lorenzini I, Majić S, Yang WHo, Heffer M, Tiemeyer M et al..  2012.  Biosynthesis of the major brain gangliosides GD1a and GT1b.. Glycobiology. 22(10):1289-301.
Jenning S, Pham T, Ireland SKale, Ruoslahti E, Biliran H.  2013.  Bit1 in anoikis resistance and tumor metastasis.. Cancer Lett. 333(2):147-51.
Fogal V, Sugahara KN, Ruoslahti E, Christian S.  2009.  Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature.. Angiogenesis. 12(1):91-100.
Teesalu T, Sugahara KN, Kotamraju VRamana, Ruoslahti E.  2009.  C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration.. Proc Natl Acad Sci U S A. 106(38):16157-62.
She Z-G, Liu X, Kotamraju VR, Ruoslahti E.  2014.  Clot-targeted micellar formulation improves anticoagulation efficacy of bivalirudin.. ACS Nano. 8(10):10139-49.
Sugahara KN, Teesalu T, Karmali PPrakash, Kotamraju VRamana, Agemy L, Greenwald DR, Ruoslahti E.  2010.  Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.. Science. 328(5981):1031-5.
Luni C, Marth JD, Doyle FJ.  2012.  Computational modeling of glucose transport in pancreatic β-cells identifies metabolic thresholds and therapeutic targets in diabetes.. PLoS One. 7(12):e53130.
Simberg D, Zhang W-M, Merkulov S, McCrae K, Park J-H, Sailor MJ, Ruoslahti E.  2009.  Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo.. J Control Release. 140(3):301-5.
Park J-H, von Maltzahn G, Xu MJue, Fogal V, Kotamraju VRamana, Ruoslahti E, Bhatia SN, Sailor MJ.  2010.  Cooperative nanomaterial system to sensitize, target, and treat tumors.. Proc Natl Acad Sci U S A. 107(3):981-6.
Park J-H, von Maltzahn G, Ong LL, Centrone A, T Hatton A, Ruoslahti E, Bhatia SN, Sailor MJ.  2010.  Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery.. Adv Mater. 22(8):880-5.
Yang WHo, Nussbaum C, Grewal PK, Marth JD, Sperandio M.  2012.  Coordinated roles of ST3Gal-VI and ST3Gal-IV sialyltransferases in the synthesis of selectin ligands.. Blood. 120(5):1015-26.
Wang H, Zhang W, Tang R, Hebbel RP, M Kowalska A, Zhang C, Marth JD, Fukuda M, Zhu C, Huo Y.  2009.  Core2 1-6-N-glucosaminyltransferase-I deficiency protects injured arteries from neointima formation in ApoE-deficient mice.. Arterioscler Thromb Vasc Biol. 29(7):1053-9.
Wang H, Tang R, Zhang W, Amirikian K, Geng Z, Geng J, Hebbel RP, Xia L, Marth JD, Fukuda M et al..  2009.  Core2 1-6-N-glucosaminyltransferase-I is crucial for the formation of atherosclerotic lesions in apolipoprotein E-deficient mice.. Arterioscler Thromb Vasc Biol. 29(2):180-7.
Lee SHo, Yu S-Y, Nakayama J, Khoo K-H, Stone EL, Fukuda MN, Marth JD, Fukuda M.  2010.  Core2 O-glycan structure is essential for the cell surface expression of sucrase isomaltase and dipeptidyl peptidase-IV during intestinal cell differentiation.. J Biol Chem. 285(48):37683-92.
Alberici L, Roth L, Sugahara KN, Agemy L, Kotamraju VR, Teesalu T, Bordignon C, Traversari C, Rizzardi G-P, Ruoslahti E.  2013.  De novo design of a tumor-penetrating peptide.. Cancer Res. 73(2):804-12.
Döring Y, Noels H, Mandl M, Kramp B, Neideck C, Lievens D, Drechsler M, Megens RTA, Tilstam PV, Langer M et al..  2014.  Deficiency of the sialyltransferase St3Gal4 reduces Ccl5-mediated myeloid cell recruitment and arrest: short communication.. Circ Res. 114(6):976-81.
Karmali PPrakash, Chao Y, Park J-H, Sailor MJ, Ruoslahti E, Esener SC, Simberg D.  2012.  Different effect of hydrogelation on antifouling and circulation properties of dextran-iron oxide nanoparticles.. Mol Pharm. 9(3):539-45.
Simberg D, Park J-H, Karmali PP, Zhang W-M, Merkulov S, McCrae K, Bhatia SN, Sailor M, Ruoslahti E.  2009.  Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance.. Biomaterials. 30(23-24):3926-33.
Rumjantseva V, Grewal PK, Wandall HH, Josefsson EC, Sørensen ALouise, Larson G, Marth JD, Hartwig JH, Hoffmeister KM.  2009.  Dual roles for hepatic lectin receptors in the clearance of chilled platelets.. Nat Med. 15(11):1273-80.
Kastantin M, Ananthanarayanan B, Karmali P, Ruoslahti E, Tirrell M.  2009.  Effect of the lipid chain melting transition on the stability of DSPE-PEG(2000) micelles.. Langmuir. 25(13):7279-86.
Pang H-B, Braun GB, Friman T, Aza-Blanc P, Ruidiaz ME, Sugahara KN, Teesalu T, Ruoslahti E.  2014.  An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability.. Nat Commun. 5:4904.

Pages